ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

House: NCI Should Coordinate National Cancer Program

August 4, 1995

Drug Development Effort Criticized

April 18, 1975

NCAB To Seek Changes In Cancer Act Renewal, Budget Improvements

November 20, 1987

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989